These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25551830)

  • 1. Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.
    Johansson G; Peng PC; Huang PY; Chien HF; Hua KT; Kuo ML; Chen CT; Lee MJ
    PLoS One; 2014; 9(12):e115916. PubMed ID: 25551830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble AXL as a marker of disease progression and survival in melanoma.
    Flem-Karlsen K; Nyakas M; Farstad IN; McFadden E; Wernhoff P; Jacobsen KD; Flørenes VA; Mælandsmo GM
    PLoS One; 2020; 15(1):e0227187. PubMed ID: 31917795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating soluble Axl as a biomarker for glioblastoma: A pilot study.
    Raymond D; Fukui M; Zwernik S; Kassam A; Rovin R; Akhtar P
    PLoS One; 2024; 19(7):e0301739. PubMed ID: 38968207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.
    Reichl P; Fang M; Starlinger P; Staufer K; Nenutil R; Muller P; Greplova K; Valik D; Dooley S; Brostjan C; Gruenberger T; Shen J; Man K; Trauner M; Yu J; Gao CF; Mikulits W
    Int J Cancer; 2015 Jul; 137(2):385-394. PubMed ID: 25529751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood.
    Ekman C; Stenhoff J; Dahlbäck B
    J Thromb Haemost; 2010 Apr; 8(4):838-44. PubMed ID: 20088931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.
    Dengler M; Staufer K; Huber H; Stauber R; Bantel H; Weiss KH; Starlinger P; Pock H; Klöters-Plachky P; Gotthardt DN; Rauch P; Lackner C; Stift J; Brostjan C; Gruenberger T; Kumada T; Toyoda H; Tada T; Weiss TS; Trauner M; Mikulits W
    Oncotarget; 2017 Jul; 8(28):46234-46248. PubMed ID: 28526812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum.
    Budagian V; Bulanova E; Orinska Z; Duitman E; Brandt K; Ludwig A; Hartmann D; Lemke G; Saftig P; Bulfone-Paus S
    Mol Cell Biol; 2005 Nov; 25(21):9324-39. PubMed ID: 16227584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axl is related to inflammation in hemodialysis patients.
    Li M; Xue W; Li X; Song Y; Liu X; Qin L
    Mol Immunol; 2021 May; 133():146-153. PubMed ID: 33667984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Axl Is a Novel Diagnostic Biomarker of Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection.
    Song X; Wu A; Ding Z; Liang S; Zhang C
    Cancer Res Treat; 2020 Jul; 52(3):789-797. PubMed ID: 32138467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AXL receptor tyrosine kinase is increased in patients with heart failure.
    Batlle M; Recarte-Pelz P; Roig E; Castel MA; Cardona M; Farrero M; Ortiz JT; Campos B; Pulgarín MJ; Ramírez J; Pérez-Villa F; García de Frutos P
    Int J Cardiol; 2014 May; 173(3):402-9. PubMed ID: 24681018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo turnover and biodistribution of soluble AXL: implications for biomarker development.
    Tenstad O; Christakou E; Hodneland Nilsson L; Gausdal G; Micklem D; Kursula P; Lorens JB; Reed RK
    Sci Rep; 2024 Jul; 14(1):16141. PubMed ID: 38997436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus.
    Ekman C; Jönsen A; Sturfelt G; Bengtsson AA; Dahlbäck B
    Rheumatology (Oxford); 2011 Jun; 50(6):1064-9. PubMed ID: 21278074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction.
    Caldentey G; García De Frutos P; Cristóbal H; Garabito M; Berruezo A; Bosch X; San Antonio R; Flores-Umanzor E; Perea RJ; De Caralt TM; Rodríguez J; Ortiz-Pérez JT
    Eur Heart J Acute Cardiovasc Care; 2019 Dec; 8(8):708-716. PubMed ID: 29119801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of sAxl are associated with severe preeclampsia.
    Liu X; Gong Y; Jia J; Bai Y; Gui S; Wang T; Zhou R
    Clin Biochem; 2014 Feb; 47(3):173-6. PubMed ID: 24239956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.
    Varin J; Poulain L; Hivelin M; Nusbaum P; Hubas A; Laurendeau I; Lantieri L; Wolkenstein P; Vidaud M; Pasmant E; Chapuis N; Parfait B
    Oncotarget; 2016 Jun; 7(24):35753-35767. PubMed ID: 26840085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl as markers of large abdominal aortic aneurysms.
    Ekman C; Site DF; Gottsäter A; Lindblad B; Dahlbäck B
    Clin Biochem; 2010 Jan; 43(1-2):110-4. PubMed ID: 19660445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes.
    Ekman C; Linder A; Akesson P; Dahlbäck B
    Crit Care; 2010; 14(4):R158. PubMed ID: 20731857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
    Friedrich RE; Beer C; Glatzel M; Hagel C
    Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
    Friedrich RE; Keiner D; Hagel C
    Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.